Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

32.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.1K
Epigenetic Regulation01:37

Epigenetic Regulation

3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Master Transcription Regulators02:23

Master Transcription Regulators

7.4K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026
Same author

<i>FMR1</i> gene therapy restores activity-driven inhibition and prevents audiogenic seizures in <i>Fmr1</i> <sup>-/<i>y</i></sup> mice.

bioRxiv : the preprint server for biology·2026
Same author

A progeria syndrome links DNA hypermethylation to age-related pathology.

Nature genetics·2026
Same author

Dysfunction of a SET3-like complex underlies a family of related neurological disorders.

Nature communications·2026
Same author

A time-resolved atlas of histone modifications during mitotic entry.

Molecular cell·2026
Same author

MeCP2 requires interactions with nucleosome linker DNA to read chromatin DNA methylation.

Nature communications·2026

Related Experiment Video

Updated: Nov 18, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

27.9K

Neuronal non-CG methylation is an essential target for MeCP2 function.

Rebekah Tillotson1, Justyna Cholewa-Waclaw1, Kashyap Chhatbar1

  • 1Wellcome Centre for Cell Biology, University of Edinburgh, The Michael Swann Building, King's Buildings, Max Born Crescent, Edinburgh EH9 3BF, UK.

Molecular Cell
|February 9, 2021
PubMed
Summary

MeCP2 protein interaction with non-CG methylation sites, like mCAC, is crucial for normal brain function. Disrupting this interaction causes Rett syndrome-like symptoms in mice.

Keywords:
DNA methylationMeCP2Rett syndromeepigenetic readermouseneuronal maintenancetranscriptional regulation

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.0K
Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

7.5K

Related Experiment Videos

Last Updated: Nov 18, 2025

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

27.9K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.0K
Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

7.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Epigenetics

Background:

  • DNA methylation plays a role in neuronal biology, particularly through the MeCP2 protein.
  • Mutations in MeCP2 cause Rett syndrome, a severe neurological disorder.
  • MeCP2 binds to both CG and non-CG methylation sites, with non-CG methylation being abundant in neurons.

Purpose of the Study:

  • To investigate the biological significance of MeCP2's dual-binding specificity.
  • To determine if interaction with non-CG methylation sites is essential for normal brain function.

Main Methods:

  • A domain-swap mouse model was created by replacing MeCP2's DNA binding domain with that of MBD2.
  • MBD2's domain specifically binds only to methylated CG (mCG) motifs, not non-CG motifs.
  • Phenotypic analysis of the resulting knockin mice was performed.

Main Results:

  • Knockin mice expressing the domain-swap protein exhibited severe Rett syndrome-like phenotypes.
  • This indicates that MeCP2's interaction with non-CG methylation sites, specifically mCAC, is essential for normal brain function.
  • The findings support the hypothesis that the delayed onset of Rett syndrome is linked to the postnatal accumulation of mCAC and MeCP2.

Conclusions:

  • Normal brain function necessitates MeCP2's interaction with non-CG methylation sites.
  • The study highlights the critical role of non-CG methylation in neuronal development and Rett syndrome pathogenesis.
  • Dysregulated genes in Mecp2 null and domain-swap mice may offer insights into potential therapeutic targets for neurological disorders.